Regulatory Story | |||
Go to market news section | |||
|
12th February 2020
Centrica plc
('The Company')
Board Announcement
Statement regarding Charles Berry, Centrica Chairman
Centrica plc (the 'Company') announces that, due to an unanticipated medical condition, the Company's Chairman, Charles Berry, is taking a leave of absence.
We wish him well and expect him to return to his duties shortly. Until his return, Scott Wheway will be acting as interim Chairman.
ENDS
Enquiries:
Investors/analysts 01753 494900 ir@centrica.com
Media 01784 843000 media@centrica.com
Centrica plc is listed on the London Stock Exchange (CNA)
Registered Office: Millstream, Maidenhead Road, Windsor, Berkshire SL4 5GD
Registered in England & Wales number: 3033654
Legal Entity Identifier number: E26EDV109X6EEPBKVH76
ISIN number: GB00B033F229
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
London Stock Exchange plc is not responsible for and does not check content on this Website. Website users are responsible for checking content. Any news item (including any prospectus) which is addressed solely to the persons and countries specified therein should not be relied upon other than by such persons and/or outside the specified countries. Terms and conditions, including restrictions on use and distribution apply. |
©2014London Stock Exchange plc. All rights reserved |
Statement regarding Centrica Chairman - RNS
Attachments
- Original document
- Permalink
Disclaimer
Centrica plc published this content on 12 February 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 12 February 2020 14:03:07 UTC